|Grant ID: RR180016|
Recruitment of Rising Stars
Icahn School of Medicine at Mount Sinai
February 21, 2018
Liver cancer is on the rise in Texas — already double the national average — and is the only cancer in the U.S. with an increasing death rate. A specialist in the development of liver cancer, who hopes to better predict who will get liver cancer and improve the odds of survival for those who do, has joined the faculty at The University of Texas Southwestern Medical Center.
Dr. Yujin Hoshida, a physician-scientist, was recruited in 2018 from Icahn School of Medicine at Mount Sinai with the help of a Recruitment of Rising Stars Award from CPRIT. He directs the Liver Tumor Translational Research Program at UT Southwestern.